{"id":"W1980747619","doi":"10.1053/j.seminoncol.2009.10.014","title":"Clinical Development of Temsirolimus, a Novel mTOR Inhibitor, for Treatment of Advanced Malignancies","year":2009,"lang":"en","type":"editorial","venue":"Seminars in Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Temsirolimus; Discovery and development of mTOR inhibitors; Medicine; PI3K/AKT/mTOR pathway; Sirolimus; Oncology; Cancer research; Internal medicine; Signal transduction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007684603,0.0004418636,0.00138195,0.0001525313,0.000036986,0.000003975382,0.0004169479,0.002187592,0.000006437822],"category_scores_gemma":[0.0009952366,0.0004315883,0.0003387046,0.0001157269,0.0002788308,0.000003126898,0.0001100488,0.0001872692,0.000001077806],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005186023,"about_ca_system_score_gemma":0.003380505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001237732,"about_ca_topic_score_gemma":0.000176812,"domain_scores_codex":[0.9967,0.0001066334,0.001623997,0.0007977351,0.0003061022,0.0004654755],"domain_scores_gemma":[0.997263,0.0006715595,0.00103171,0.0005315041,0.0004109916,0.0000912701],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003335115,0.002492917,0.0003346865,0.0003028659,0.0003281408,0.00001124416,0.0004426427,0.00008281258,0.3711311,0.00001168388,0.4575875,0.1639393],"study_design_scores_gemma":[0.004120028,0.009400465,0.00006954817,0.0003691041,0.00007031305,0.000002646144,0.00006366645,0.000003587224,0.1464569,0.00002529522,0.839102,0.0003163902],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.3242371,0.0163278,0.0008330985,0.00008135886,0.6543266,0.002307791,0.001109627,0.0000253412,0.000751304],"genre_scores_gemma":[0.02191765,0.01600855,0.2365904,0.0001525844,0.7137286,0.001728544,0.004131893,0.000301152,0.00544058],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.3815145,"threshold_uncertainty_score":0.9998136,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02357649989753213,"score_gpt":0.371626267336534,"score_spread":0.3480497674390018,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}